PERIOGARD

Post-LOE

chlorhexidine gluconate

Johnson & Johnson

ANDADENTALSOLUTION

Approved

Jan 1994

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

4/8 — Partial

PERIOGARD (chlorhexidine gluconate) by Johnson & Johnson is clinical pharmacology periogard® (chlorhexidine gluconate oral rinse usp, 0. Approved for bacteria, general skin cleanser: helps reduce bacteria on the skin. First approved in 1994.

Drug data last refreshed 21h ago

$0.0BPart D

Mechanism of Action

CLINICAL PHARMACOLOGY PerioGard® (Chlorhexidine Gluconate Oral Rinse USP, 0.12%) provides antimicrobial activity during oral rinsing. The clinical significance of chlorhexidine gluconate oral rinse's antimicrobial activities is not clear. Microbiological sampling of plaque has shown a general…

Indications (2)

Worked on PERIOGARD at Johnson & Johnson? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.